Amexdrug Corporation
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of p… Read more
Market Cap & Net Worth: Amexdrug Corporation (AXRX)
Amexdrug Corporation (PINK:AXRX) has a market capitalization of $338.82K ($338.82K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50646 globally and #15488 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amexdrug Corporation's stock price $0.00 by its total outstanding shares 169409620 (169.41 Million).
Amexdrug Corporation Market Cap History: 2015 to 2025
Amexdrug Corporation's market capitalization history from 2015 to 2025. Data shows change from $16.94 Million to $338.82K (-33.85% CAGR).
Amexdrug Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amexdrug Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
Amexdrug Corporation's market cap is 0.10 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
29.63x
Amexdrug Corporation's market cap is 29.63 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $16.94 Million | $8.85 Million | $100.31K | 1.91x | 168.88x |
| 2016 | $14.21 Million | $9.30 Million | $73.76K | 1.53x | 192.70x |
| 2017 | $40.66 Million | $10.43 Million | $111.36K | 3.90x | 365.09x |
| 2018 | $18.80 Million | $10.51 Million | $201.40K | 1.79x | 93.37x |
| 2019 | $9.83 Million | $7.72 Million | $216.89K | 1.27x | 45.30x |
| 2020 | $13.55 Million | $6.37 Million | $195.99K | 2.13x | 69.15x |
| 2021 | $25.41 Million | $4.82 Million | $74.19K | 5.27x | 342.51x |
| 2023 | $338.82K | $3.92 Million | $35.83K | 0.09x | 9.46x |
| 2024 | $338.82K | $3.40 Million | $11.44K | 0.10x | 29.63x |
Competitor Companies of AXRX by Market Capitalization
Companies near Amexdrug Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Amexdrug Corporation by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Amexdrug Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Amexdrug Corporation's market cap moved from $16.94 Million to $ 338.82K, with a yearly change of -33.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $338.82K | 0.00% |
| 2024 | $338.82K | 0.00% |
| 2023 | $338.82K | -98.82% |
| 2022 | $28.80 Million | +13.33% |
| 2021 | $25.41 Million | +87.50% |
| 2020 | $13.55 Million | +37.93% |
| 2019 | $9.83 Million | -47.75% |
| 2018 | $18.80 Million | -53.75% |
| 2017 | $40.66 Million | +186.05% |
| 2016 | $14.21 Million | -16.10% |
| 2015 | $16.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Amexdrug Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $338.82K USD |
| MoneyControl | $338.82K USD |
| MarketWatch | $338.82K USD |
| marketcap.company | $338.82K USD |
| Reuters | $338.82K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.